LabMed Discovery

Elsevier

Journal websitePeer review: Other
Evaluation status available after sign-in

About the journal

LabMed Discovery is an open-access journal published by Elsevier in China, publishing in english. It is listed in DOAJ according to the sources read. Declared review time at DOAJ: 24 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Elsevier
ISSN
3050-4740
Country
China
Languages
english
Access
Open access
Articles in DOAJ
59
Declared review time
24 weeks
Declared peer-review model
other

Index listings

  • DOAJ · 2025-08-19
Indexing
DOAJ
APC
—
Declared review time (DOAJ)
24 weeks — journal-declared only (not measured)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Articles in DOAJ

59

Most recent article

8 months ago

Average review time (journal-declared via DOAJ)

24weeks

Works in OpenAlex

70

Last recorded publication year

2025

Reported by OpenAlex in 1 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

7

i10-index

4

From OpenAlex open data (CC0).

Editorial & policy10
Last DOAJ review date
2026-04-27
Added to DOAJ
2025-08-19
Declared plagiarism screening
Declared
Other fees beyond APC
No
Declared digital preservation
CLOCKSSPortico
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
CLOCKSSPortico
Editorial board
Official page ↗
Open references deposited at Crossref
87%
ORCID iDs in current deposits
62%
Deposits licence metadata at Crossref
✓
Peer-review policy
View policy
Identity & continuity2
Alternate titles
LabMed discovery
Source type
journal
Classification2

Subjects (DOAJ)

Medicine: Internal medicine

LCC codes

RC31-1245

Subject areas

  • Clinical Laboratory Practices and Quality Control
  • Clinical Laboratory Practices and Quality Control
  • Clinical Laboratory Practices and Quality Control
  • Metabolomics and Mass Spectrometry Studies
  • Cancer Genomics and Diagnostics
  • Artificial Intelligence in Healthcare and Education
  • Single-cell and spatial transcriptomics
  • Single-cell and spatial transcriptomics
Show all subjects (75)
  • Metabolomics and Mass Spectrometry Studies
  • Biosensors and Analytical Detection
  • Metabolomics and Mass Spectrometry Studies
  • Blood Coagulation and Thrombosis Mechanisms
  • Blood groups and transfusion
  • Artificial Intelligence in Healthcare and Education
  • Monoclonal and Polyclonal Antibodies Research
  • Blood Coagulation and Thrombosis Mechanisms
  • Cancer Immunotherapy and Biomarkers
  • Genetic Associations and Epidemiology
  • Computational Drug Discovery Methods
  • Blood Coagulation and Thrombosis Mechanisms
  • Cancer Immunotherapy and Biomarkers
  • Bacterial Identification and Susceptibility Testing
  • Technology and Human Factors in Education and Health
  • Platelet Disorders and Treatments
  • Tuberculosis Research and Epidemiology
  • Blood groups and transfusion
  • Mass Spectrometry Techniques and Applications
  • Monoclonal and Polyclonal Antibodies Research
  • Microfluidic and Capillary Electrophoresis Applications
  • T-cell and B-cell Immunology
  • Clinical practice guidelines implementation
  • Radiomics and Machine Learning in Medical Imaging
  • Diet and metabolism studies
  • Hormonal Regulation and Hypertension
  • Ferroptosis and cancer prognosis
  • Hemophilia Treatment and Research
  • Neuroendocrine Tumor Research Advances
  • Folate and B Vitamins Research
  • Vitamin D Research Studies
  • SARS-CoV-2 and COVID-19 Research
  • Atrial Fibrillation Management and Outcomes
  • COVID-19 Clinical Research Studies
  • Parathyroid Disorders and Treatments
  • Vitamin D Research Studies
  • Cancer Immunotherapy and Biomarkers
  • COVID-19 Clinical Research Studies
  • Animal Disease Management and Epidemiology
  • Autism Spectrum Disorder Research
  • Cancer Genomics and Diagnostics
  • Extracellular vesicles in disease
  • MicroRNA in disease regulation
  • AI in cancer detection
  • Biomedical and Engineering Education
  • COVID-19 Clinical Research Studies
  • Ferroptosis and cancer prognosis
  • Artificial Intelligence in Healthcare and Education
  • Hormonal Regulation and Hypertension
  • Diet and metabolism studies
  • Clinical practice guidelines implementation
  • Atrial Fibrillation Management and Outcomes
  • SARS-CoV-2 and COVID-19 Research
  • Vitamin D Research Studies
  • Folate and B Vitamins Research
  • Neuroendocrine Tumor Research Advances
  • Hemophilia Treatment and Research
  • Animal Disease Management and Epidemiology
  • MicroRNA in disease regulation
  • Cancer Genomics and Diagnostics
  • Epigenetics and DNA Methylation
  • Extracellular vesicles in disease
  • Gut microbiota and health
  • Advanced biosensing and bioanalysis techniques
  • Cancer-related molecular mechanisms research
  • MicroRNA in disease regulation
  • AI in cancer detection

Keywords (DOAJ)

  • analytical chemistry
  • testing techniques
  • dna sequencing
  • personalized laboratory medicine

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: